|
INTERMEDIATEs for APIs
|
CAS No. |
|
Adapalene intermediates |
|
|
2-(1-Adamantyl)-4-bromoanisole |
104224-63-7 |
|
6-Bromo-2-naphtoic acid methyl ester |
33626-98-1 |
|
|
|
|
Alendronate sodium intermediates |
|
|
Alendronic acid |
66376-36-1 |
|
|
|
|
Aliskirin intermediates |
|
|
3-Amino-2,2-dimethylpropionamide |
324763-51-1 |
|
(2S,4E)-5-Chloro-N,N-dimethyl-2-(1-methylethyl)-4-pentenamide |
324519-68-8 |
|
4-[(2R)-2-(Chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene |
324763-39-5 |
|
4-[(2R)-2-(Bromomethyl)-3-methylbutyl]-1-methoxy-2-(3-Methoxypropoxy)benzene |
172900-69-5 |
|
|
|
|
Amfebutamone intermediates |
|
|
3'-Chloropropiophenone |
34841-35-5 |
|
|
|
|
Anastrozole intermediates |
|
|
2,2'-(5-Methyl-1,3-phenylene)-di-(2-methylpropionitrile)/3,5-Bis-(2-cyanoisopropyl) toluene |
120511-72-0 |
|
3,5-Bis(2-cyanoisopropyl)benzalcohol |
|
|
2,2'-(5-Bromomethyl-1,3-phenylene)-di-(2-methylpropiononitrile) / 3,5-Bis(2-cyanoisopropyl)bromomethyl benzene |
120511-84-4 |
|
|
|
|
Aripiprazole intermediates |
129722-12-9 |
|
7HQ / 7-Hydroxy-3,4-dihydroquinazolone |
22246-18-0 |
|
BBQ / 7-(4-Bromobutoxy)-3,4-dihydroquinazolone |
129722-34-5 |
|
DCP / 1-(2,3-Dichlorophenyl) piperazine monohydrochloride |
119532-26-2 |
|
|
|
|
Articaine intermediates |
|
|
Methyl 3-amino-4-methylthiophene-2-carboxylate |
85006-31-1 |
|
|
|
|
Atorvastatin intermediates |
|
|
ATS-8 / (4R,Cis)-t-Butyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate |
129571-94-0 |
|
ATS-9 / (4R-Cis)-1,1-dimethylethyl-6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-acetate |
125995-13-3 |
|
M4 / 4-Fluoro-alpha-[2-methyl-1-oxopropyl]-gamma-oxo-N,beta-diphenylbenzene butaneamide |
125971-96-2 |
|
L-1 / (4R-cis)-1,1-Dimethylethyl-6-[2-[2-(4-fluorophenyl)-5-(1-isopropyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetate |
125971-95-1 |
|
|
|
|
Aztreonam intermediates |
|
|
Azeditine / (2S,3S)-3-Amino-2-methyl-4-oxo-1-azetidinesulfonic acid |
80082-65-1 |
|
TAEM / 2-Mercaptobenzothiazolyl (Z)-2-(2-aminothiazol-4-yl)-2-(2-tert-butorycarbonylprop-2-oxyimino) acetate |
158183-05-2 |
|
|
|
|
Benazepril intermediates |
|
|
4-Nitrobenzenesulfonyl chloride |
98-74-8 |
|
Tert butyl-3-(3s) amino-2,3,4,5-tetrahydro-1H(1) benzazepin-2-one-1-acetate |
109010-60-8 |
|
|
|
|
Betaxolol intermediates |
|
|
4-HEP / 4-(2-Hydroxyethyl)-phenol |
501-94-0 |
|
|
|
|
Bicalutamide intermediates |
|
|
4-Cyano-3-trifluoromethyl aniline |
654-70-6 |
|
Bica Oxirane / N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methyl-2-oxirane carboxamide |
90357-51-0 |
|
ASH Bicalutamide / N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenylthio)-2-hydroxy-2-methyl-propionamide |
90356-78-8 |
|
|
|
|
Candesartan intermediates |
|
|
Trityl candesartan cilexetil |
170791-09-0 |
|
Trityl candesartan |
139481-72-4 |
|
|
|
|
Capecitabine intermediates |
|
|
5'-Deoxy-5-fluorocytidine |
66335-38-4 |
|
2',3'-Di-o-acetyl-5'-deoxy-5-fluorocytidine |
161599-46-8 |
|
|
|
|
Carvedilol intermediates |
|
|
4-(2,3-Epoxypropoxy)carbazole |
51997-51-4 |
|
2-(2-Methoxyphenoxy) ethylamine |
1836-62-0 |
|
|
|
|
Cilostazole intermediates |
|
|
6-HQ / 6-Hydroxy-2-oxo-1,2,3,4-tetrahydro-quinolinone |
54197-66-9 |
|
CHCBT / 5-(4-Chlorobutyl)-1-cyclohexyl-1H-tetrazole |
73693-42-5 |
|
|
|
|
Cinacalcet intermediates |
|
|
TFT Propyl alcohol / 3-(3'-Trifluoromethylphenyl)-propyl alcohol |
78573-45-2 |
|
|
|
|
Clopidogrel intermediates |
|
|
TTP / 4,5,6,7-Tetrahydrothieno[3,2-c]pyridine HCl |
28783-41-7 |
|
CL5.HCl / D-(+)-Methyl-alpha-(2-thienylethamino)(2-chlorophenyl)acetate HCl |
141109-19-5 |
|
CL6 Bisulfate / Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate Bisulfate |
135046-48-9 |
|
CL6 HCl / Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate HCl |
|
|
CL7 / (+)-(2-Chlorophenyl)-(6,7-dihydro-4h-thieno[3,2-c]pyridine-5-yl)acetic acid methyl ester, (-)-camphorsulphomic acid |
|
|
|
|
|
Doripenem intermediates |
|
|
Doripenem side chain / 4-Nitrobenzyl(2S,4S)-4-acetylthio-2-[[N-sulfamoyl-N-(tert-butoxycarbonyl)amino] methyl]pyrrolidine-1-carboxylate |
491878-06-9 |
|
|
|
|
Duloxetine intermediates |
|
|
1-Fluoro naphthalene |
321-38-0 |
|
3-Dimethylamino-1-(2-thienyl)-1-propanone |
13196-35-5 |
|
(S)-(+)-N,N-Dimethyl-3-hydroxy-3-(2-thiophene) propylamine |
132335-44-5 |
|
(DLX-Me)Oxal / (S)-(+)-N,N-Dimethyl-3-Napthtoxy-(2-Thiophene) propylamine oxalate |
132335-47-8 |
|
|
|
|
Efavirenz intermediates |
|
|
CPA / Cyclopropyl acetylene |
6746-94-7 |
|
SD570 / 4-Chloro-2-(1,1-dihydroxy-2,2,2-trifluoroethyl) aniline HCl |
173676-59-0 |
|
|
|
|
Erlotinib intermediates |
|
|
6,7-Bis-(2-methoxyethoxy)-quinazolin-4(3H)-one |
179688-29-0 |
|
4-Chloro-6,7-(2-methoxyethoxy)-quinazoline |
183322-18-1 |
|
|
|
|
Eszopiclone intermediates |
|
|
6-(5-Chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one |
43200-81-3 |
|
|
|
|
Etodolac intermediates |
|
|
Methyl 3-oxopentanoate |
30414-53-0 |
|
7-Ethyltryptophol |
41340-36-7 |
|
|
|
|
Fexofenadine intermediates |
|
|
F5 / Methyl 2-(4-(4-chlorobutanoyl)phenyl)-2-methylpropanoate |
154477-54-0 |
|
F6 / Keto methyl ester / Methyl 4-[4-[4-(hydroxy diphenyl methyl)-1-piperidinyl] -1-oxobutyl]-alpha,alpha-dimethyl phenylacetate |
154477-55-1 |
|
|
|
|
Flecainide intermediates |
|
|
2,5-Bis (2,2,2-trifluoroethoxy)-benzoic acid |
35480-52-5 |
|
|
|
|
Fluridil intermediates |
|
|
4-Nitro-3-trifluoromethyl aniline |
393-11-3 |
|
3-Amino-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)-phenyl]-propanamide |
279228-81-8 |
|
|
|
|
Fluvastatine intermediates |
|
|
Fluvaldehyde / 3-(3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2yl)-propenal |
93957-50-7 |
|
Fluva diol-t-Bu / t-Butyl (E)-3,5-dihydroxy-7-[3'-(4''-fluorophenyl)-1' -methylethyl-indol-2'-yl]-6-heptenoate |
129332-29-2 |
|
|
|
|
Furosemide intermediates |
|
|
Lasamide / DSBA / 2,4-Dichloro-5-sulfamoylbenzoic acid |
2736-23-4 |
|
|
|
|
Ganciclovir intermediates |
|
|
AMDCP / 2-Acetoxymethoxy-1,3-dichloropropane |
89281-73-2 |
|
|
|
|
Gemcitabine intermediates |
|
|
2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate |
122111-01-7 |
|
|
|
|
Imatinib intermediates |
|
|
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinamine |
52460-10-1 |
|
4-[(4-Methyl-1-piperazinyl)methyl]benzoic acid DiHCl |
106261-49-8 |
|
4-Chloromethyl-N-[4-methyl-3-[[4-(pyridinyl-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide |
404844-11-7 |
|
|
|
|
Letrozole intermediates |
|
| 4-(1H-1,2,4-Triazol-1-ylmethyl)-benzonitrile |
112809-25-3 |
|
|
|
|
Levocetirizine intermediates |
|
|
(R)-1-[(4-Chlorophenyl) phenylmethyl]piperazine |
130018-88-1 |
|
|
|
|
Linezolid intermediates |
|
| FMO-Hydroxy / R-N-(3-Fluoro-4-morpholinylphenyl)-2-r-oxo-5-oxazolidinyl methanol |
|
|
Azide / R-N-(3-Fluoro-4-morphlinylphenyl)-2-oxo-5-oxazoleidinyl methyl azide |
168828-84-0 |
|
|
|
|
Memantine intermediates |
|
|
1,3-Dimethyladamantane |
702-79-4 |
|
1-Bromo-3,5-dimethyladamantane |
941-37-7 |
|
|
|
|
Meropenem intermediates |
|
|
OASA / 4AA / Acetoxysilyloxyazetidinone / 4-Acetoxyazetidin-2-one |
76855-69-1 |
|
4-BMA / Beta-Methylazetidin-2-one |
90776-58-2 |
|
Beta-Methyl vinyl phosphate / MAP |
90776-59-3 |
|
Meropenem side chain |
96034-64-9 |
|
Meropenem crude |
119478-56-7 |
|
|
|
|
Metoprolol intermediates |
|
|
4-MEP / 4-(2-Methoxyethyl)-phenol |
56718-71-9 |
|
|
|
|
Mirtazapine intermediates |
|
|
NMPP / 1-Methyl-3-phenylpiperazine |
5271-27-2 |
|
|
|
|
Montelukast intermediates |
|
|
1,1-Cyclopropane dimethanol |
39590-81-3 |
|
1-Hydroxymethyl cyclopropyl acetonitrile |
152922-71-9 |
|
1-(Mercaptomethyl)-cyclopropaneacetic acid |
162515-68-6 |
|
Cytam / 1-(Mercaptomethyl)-cyclopropaneacetic acid methyl ester |
152922-73-1 |
|
|
|
|
|
|
|
Olanzapine intermediates |
|
|
TBD / 4-Amino-2-methyl-10H-thieno(2,3-b)(1,5) benzodiazepine HCl |
138564-60-0 |
|
OL4 / N-Demethylolanzapine |
161696-76-0 |
|
|
|
|
Olmesartan medoxomil intermediates |
144689-63-4 |
|
4-(Chloromethyl)-5-methyl-1,3-dioxol-2-one |
80841-78-7 |
|
4-(1-Hydroxy-1-methylethyl)-2-propyl-1H-imidazole-5-carboxylic acid ethyl ester |
144689-93-0 |
|
Trityl olmesartan medoxomil |
144690-92-6 |
|
5-[(4'-Bromomethyl)-1,1'-biphenyl-2-yl]-1-trityl-1H-tetrazole |
124750-51-2/ 133051-88-4 |
|
|
|
|
Oxcarbazepine intermediates |
|
|
10-Methoxy iminostilbene |
4698-11-7 |
|
|
|
|
Paclitaxel intermediates |
|
|
(3R, 4S)-3-Hydroxy-4-phenyl-2-azetidinone |
132127-34-5 |
|
(3R, 4S)-3-(1-Hydroxy)-4-(phenyl)-N-benzoyl-2-azetidinone |
149494-63-3 |
|
(3R, 4S)-3-(1-ethoxyethoxy)-4-(phenyl)-N-benzoyl-2-azetidinone |
201856-53-3 |
|
|
|
|
Paliperidone intermediates |
|
|
2-Amino-3-benzyloxypyridine |
24016-03-3 |
|
3-(2-Chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one |
130049-82-0 |
|
6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole HCl |
84163-13-3 |
|
|
|
|
Paroxetine intermediates |
78246-49-8 |
|
Trans-(-)-Paroxol / (-)-trans-4-(4-Fluorophenyl)-N-methyl-3-hydroxymethylpiperidine |
105812-81-5 |
|
NMP / N-Methyl paroxetine |
110429-36-2 |
|
Paroxetine base 85% in Toluene solution |
61869-08-7 |
|
|
|
|
Pioglitazone intermediates |
|
|
5-[4-[2-(5-Ethyl-pyridin-2-yl-ethoxy)benzylidene]thiazolidine-2,4-dione |
144809-28-9 |
|
|
|
|
Prasugrel intermediates |
|
|
5,6,7,7a-Tetrahydro-4H-thieno[3,2-c]-2-pyridone HCl |
115473-15-9 |
|
5,6,7,7a-Tetrahydro-4H-thieno[3,2-c]-2-pyridone-p-Toluene sulfonate |
178688-49-8 |
|
2-Bromo-1-cyclopropyl-2-(2-fluorophenyl)ethanone |
204205-33-4 |
|
2-Chloro-1-cyclopropyl-2-(2-fluorophenyl)ethanone |
178688-43-2 |
|
|
|
|
Pregabalin intermediates |
|
|
3-Aminomethyl-5-methylhexanoic acid |
130912-52-6 |
| 3-Aminomethyl acylmethyl-5-methylhexanoic acid |
181289-15-6 |
|
R-(-)-3-Aminomethyl acylmethyl-5-methylhexanoic acid |
181289-33-8 |
|
|
|
|
|
|
|
Quetiapine intermediates |
|
| CEE / 2-(2-Chloroethoxy)ethanol |
628-89-7 |
|
DBTP / 11-Piperazynil-dibenzo[b,f][1,4] thiazepine 2HCl |
111974-74-4 |
|
HEEP / 1-[2-(2-Hydroxyethoxy)ethyl]piperazine.2HCl |
85293-16-9 |
|
DBTO / Dibenzo[b,f][1,4] thiazepine-11-[10H] one |
3159-07-7 |
|
|
|
|
Raloxifen intermediates |
|
|
4-(2-Piperidinoethoxy) benzoic acid HCl |
84449-80-9 |
|
6-Methoxy-2-(4-methoxyphenyl)benzo[b]thiophene |
63675-74-1 |
|
|
|
|
Rebamipide intermediates |
|
|
Diethyl acetamidomalonate |
1068-90-2 |
|
|
|
|
Tiamulin |
|
|
Pleuromutilin |
125-65-5 |
|
|
|
|
Ropinirole intermediates |
|
|
4-(2-Hydroxyethyl)indolin-2-one |
139122-19-3 |
|
R4 / 2-Methyl-3-nitrophenyl acetic acid |
23876-15-5 |
|
R5 / (2-Methyl-3-nitrophenyl)-N,N-di-n-propylacetamide |
|
|
R6 / 2-Nitro-6-(di-N-propylamino)ethyl toluene |
91374-23-1 |
|
P8 / 4-(2-Tosyloxyethyl)indolin-2-one |
|
|
|
|
|
Rosiglitazone intermediates |
|
|
MPAEBT / 5-[4-[2-[N-Methyl-N-(2-pyridinyl)amino]ethoxy]benzylidene]-2,4-thiazolidinedione |
122320-74-5 |
|
4-[2-(Methyl-2-pyridinylamino)ethoxy]benzaldehyde |
122321-03-3 |
|
|
|
|
Rosuvastatin intermediates |
|
|
Dimethyl 3-hydroxyglutarate |
7250-55-7 |
|
R1 / TBRE Acetonide / Tert-butyl (E)-(6{2-[4-(4-fluorophenyl)-6-isopropyl-2-[N-methyl -N-methylsulfonyl)amino]-pyrimidin-5-yl]vinyl}-(4R,6S)-2-dimethyl[1,3] dioxan-4-yl) acetate |
289042-12-2 |
|
R1.5 / TBRE / Tert-butyl Rosuvastatin / Tert-butyl 7-[4-(4-fluorophenyl)-6-isopropyl -2-(N-methyl-N-methylsulphonylamino)-pyrimidin-5-yl]-(3R,5S) -dihydroxy-(E)-6-heptenate |
355806-00-7 |
|
J6 / Methyl (3R)-3-(tert-Butyldimethylsilyoxy)-5-oxo-6-triphenylphoranylidene hexanoate |
147118-35-2 |
|
Z-6 / 4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl-N-methylsulfonyl)amino] pyrimidine-5-carboxylate |
289042-11-1 |
|
Z8 / Diphenyl [4-(4-fluorophenyl)-6-isopropyl]-2-[N-methyl-N-methylsulphonyl)amino]pyrimidin-5-yl-methyl]phosphine oxide |
|
|
Z8.1 / FPP-Aldehyde / 4-(4-Fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulphonylamino)-5-pyrimidine-carboxaldehyde |
147118-37-4 |
|
|
|
|
Sertraline HCl intermediates |
|
|
4-(3,4-Dichlorophenyl)-1-tetralone |
79560-19-3 |
|
Sertraline racemate HCl
|
79617-99-5 |
|
Sitagliptin intermediates |
|
|
2,4,5-Trifluorophenyl acetic acid |
209995-38-0 |
|
|
|
|
Solifenacin intermediates |
|
|
(S)-1-Phenyl-1,2,3,4-tetrahydroisoquinolinone |
118864-75-8 |
|
|
|
|
Tegaserod intermediates |
|
|
AGP-HI / N-Amino-N'-pentyl guanidine hydroiodide |
169789-35-9 |
|
MICHO / 5-Methoxyindole-3-carboxaldehyde |
10601-19-1 |
|
|
|
|
Terbinafine intermediates |
|
|
Trans-1-chloro-6,6-dimethyl-2-heptene-4-yne, 90%min. |
126764-17-8 |
|
|
|
|
Tolterodine intermediates |
|
|
3-(2-Methoxy-5-methylphenyl)-3-phenyl propanol |
124937-73-1 |
|
N,N-Di-isopropyl-3-(2-methoxy-5-methylphenyl)-3-phenylpropylamine-fumaric acid salt |
124935-89-3 |
|
Tolterodine hydrobromic acid salt |
124936-74-9 |
|
|
|
|
Torasamide intermediates |
|
|
4-Chloro-3-pyridinesulfonamide |
33263-43-3 |
|
SMPAP / 4-(3-Methylphenyl)amino-3-pyridinesulfonamide |
72811-73-5 |
|
|
|
|
Tosufloxacin intermediates |
|
|
(S)-3-Pyrrolidinol HCl |
122536-94-1 |
|
|
|
|
Tramadol intermediates |
|
|
MBA / m-Bromo anisole |
2398-37-0 |
|
|
|
|
Trazodone intermediates |
|
|
1-(3-Chlorophenyl)-4-(3-chloropropyl)-piperazine HCl |
39577-43-0 |
|
1,2,4-Triazolo[4,3-a]pyridine-3(2H)-one |
6969-71-7 |
|
|
|
|
Valacyclovir intermediates |
|
|
Boc-L-Valine |
13734-41-3 |
|
Cbz-protected valyl ester / 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl- N-[(benzyloxy) carbonyl]-L-Valinate
|
124832-32-2 |